Health

Results: 1-12 of 6080

Business Wire logo

Felycin®-CA1 (Sirolimus Delayed-Release Tablets) is the First and Only Drug FDA Approved for the Management of Ventricular Hypertrophy in Cats with Subclinical Hypertrophic Cardiomyopathy (HCM), A Condition Affecting as Many as One in Seven Cats

Eviva Partners Launches New Think Tank, Exposes Attack on Aluminum-Containing Vaccines

Business Wire associated0

Guardant Health and James Van Der Beek Team Up to Raise Awareness About New Advances in Colorectal Cancer Screening for Adults 45+

PR Newswire associated0

Emerald Clinical Trials Confirms CEO Transition and Continuity Plan

PR Newswire associated0

Survey Finds Medtechs Lack Confidence in Regulatory Data Quality

PR Newswire associated0

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: SNAP BENEFITS LINKED TO SLOWER COGNITIVE DECLINE, 10-YEAR STUDY FINDS

KFSHRC Advances Robotic Surgery with a Successful Ivor Lewis Esophagectomy

IVI RMA Global Expands Footprint in Reproductive Medicine with Acquisition of ART Fertility Clinics in the United Arab Emirates and Saudi Arabia

Business Wire logo

Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression

Innovation

Photocure ASA: Results for the second quarter of 2025

PR Newswire associated0

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: ALZHEIMER'S ASSOCIATION RELEASES ITS FIRST CLINICAL PRACTICE GUIDELINE FOR BLOOD-BASED BIOMARKER TESTS